Ibuprofen Formulations: Permeability and Biodegradability Comparison Depending on the Type of Formulation

Edyta Kucharska,Berin Ok,Anna Nowak,Łukasz Kucharski,Anna Muzykiewicz-Szymańska,Paula Ossowicz-Rupniewska

DOI: https://doi.org/10.3390/pr12061236

IF: 3.5

2024-06-17

Processes

Abstract:This study assesses ibuprofen's permeability to different formulations and their biodegradation. Hydrogel, organogel, Eucerin ointment, silicone ointment, and zinc ointment were investigated. The objective was to comprehensively evaluate the therapeutic efficacy and environmental implications of these formulations. Diverse formulations were examined through the utilisation of Franz diffusion chambers to evaluate the in vitro permeability of both ibuprofen and ibuprofenate sodium. Moreover, biodegradation studies of the obtained formulations were carried out with activated sludge. The activity of the inoculum was confirmed by using SDS as a reference compound. The experimental settings used (carbon content and inoculum volume) were selected based on the criteria set by the OECD guidelines. Relevant parameters pertaining to the biodegradation process were estimated, including biodegradation values (%B) at specific time points, half-lives of initial compounds and API-containing formulations, and degradation phases (lag phase I; degradation phase II, and plate phase III). For comparison purposes, biodegradation studies were also carried out for the initial IBU and IBUNa compounds under the same conditions. The environmental implications of these findings underscore the need for a balanced consideration of therapeutic efficacy and environmental sustainability in pharmaceutical formulation design. This study provides valuable insights for pharmaceutical researchers, environmental scientists, and regulatory bodies involved in the development and assessment of drug formulations. The proposed method of removing NSAIDs from aquatic ecosystems is a cheaper alternative to techniques such as reverse osmosis, oxidation, UV degradation, or photolysis, which have not found practical use owing to the generation of toxic sludge or high capital and operating costs.

engineering, chemical

What problem does this paper attempt to address?

The problems that this paper aims to solve mainly focus on two aspects:

1. **Evaluating the skin permeability of different dosage forms of Ibuprofen and its Ibuprofenate Sodium**: The study evaluated the in - vitro permeability of Ibuprofen in hydrogels, organogels, Eucerin ointment, silicone oil ointment and zinc ointment by using Franz diffusion chambers. These evaluations are helpful for understanding the enhancement effects of different carriers on the skin permeability of drugs, thus guiding the design of more effective drug delivery systems.

2. **Comparing the biodegradability of different dosage forms**: The study also explored the biodegradation characteristics of the above - mentioned different dosage forms, especially their degradation in activated sludge. Through comparison experiments with the standard compound sodium dodecyl sulfate (SDS), the biodegradation degrees of each dosage form were evaluated, including the biodegradation rate (%B) at specific time points, the half - lives of the initial compounds and preparations containing API (active pharmaceutical ingredients), and different stages of the degradation process (lag phase I; degradation phase II, and plateau phase III). This part of the study is of great significance for evaluating the environmental impacts of pharmaceutical preparations, especially when considering the possible long - term impacts of drug residues on water ecosystems.

In conclusion, the core objective of this study is to comprehensively evaluate the therapeutic effects and environmental impacts of different dosage forms of Ibuprofen, so as to promote the balance between efficacy and environmental protection in the design of pharmaceutical preparations. This not only provides valuable insights for drug researchers, but also provides a reference basis for environmental scientists and regulatory agencies to evaluate the safety and sustainability of pharmaceutical preparations.